01-miseq reagent kit V2 (300 cycle)

Ended Awarded Last action

Contract number
HHSN26400003
Awardee
Awarding agency
Obligated
$491,802

Award facts

Opportunity
  • NIHNHLBICSBHG2015RF Solicitation number
Contract value 100% obligated
$491,802.34 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$1,213
Change Order 1 $0
Original award $493,015

About this award

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a delivery order to Illumina, Inc. on September 25, 2015, for MiSeq Reagent Kit V2 (300 cycle) with a ceiling value of $491,802.34.

Place of performance is Bethesda, MD. The order was completed on September 2, 2020, and priced on a firm fixed-price basis with no set-aside designation.

Quick answers

Who was awarded contract HHSN26400003?

HHSN26400003 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 25, 2015.

How much is contract HHSN26400003 worth?

The government has obligated $491,802 on HHSN26400003.

Is contract HHSN26400003 an order under another contract?

Yes. HHSN26400003 is a delivery order under HHSN268201500004I, an indefinite delivery contract.

Was contract HHSN26400003 competed?

The extent of competition for HHSN26400003 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award